AQVESME 100 mg/1
mitapivat · TABLET, FILM COATED · Agios Pharmaceuticals, Inc.
No Recall History
Plain English
AQVESME is a tablet, film coated containing mitapivat at 100 mg/1, taken oral. Manufactured by Agios Pharmaceuticals, Inc..
Key Facts
- Brand Name
- AQVESME
- Generic Name
- mitapivat
- NDC Code (Product)
71334-235- Manufacturer
- Agios Pharmaceuticals, Inc.
- Strength
- 100 mg/1
- Dosage Form
- TABLET, FILM COATED
- Route
- ORAL
- Marketing Status
- Application #
- NDA216196
- Drug Class
- Pyruvate Kinase Activator [EPC]
- Marketing Start
- 12/23/2025
Recall History
No Recall HistoryFrequently Asked Questions
What is AQVESME used for?
AQVESME contains mitapivat. It is a tablet, film coated taken oral. Consult your doctor for specific uses.
Is AQVESME a controlled substance?
AQVESME is not classified as a controlled substance by the DEA.
What is the generic name for AQVESME?
The generic name for AQVESME is mitapivat. There are 6 other brand versions of mitapivat.
What is the NDC code for AQVESME 100 mg/1?
The NDC (National Drug Code) for AQVESME 100 mg/1 is 71334-235, listed by Agios Pharmaceuticals, Inc..